博士論文

Lauric acid overcomes hypoxia-induced gemcitabine chemoresistance in pancreatic ductal adenocarcinoma

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Lauric acid overcomes hypoxia-induced gemcitabine chemoresistance in pancreatic ductal adenocarcinoma

Persistent ID (NDL)
info:ndljp/pid/13722127
Material type
博士論文
Author
Takagi, Tadatakaほか
Publisher
MDPI
Publication date
2023-04
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
奈良県立医科大学,博士(医学)
View All

Notes on use at the National Diet Library

Notes on use

Note (General):

type:ThesisAlthough gemcitabine (GEM) is widely used in chemotherapy for pancreatic ductal adenocarcinoma (PDA), drug resistance restricts its clinica...

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
Takagi, Tadataka
Fujiwara-Tani, Rina
Mori, Shiori
Kishi, Shingo
Nishiguchi, Yukiko
Sasaki, Takamitsu
Ogata, Ruiko
Ikemoto, Ayaka
Sasaki, Rika
Ohmori, Hitoshi
Luo, Yi
Bhawal, Ujjal Kumar
Sho, Masayuki
Kuniyasu, Hiroki
Publication, Distribution, etc.
Publication Date
2023-04
24 8
Publication Date (W3CDTF)
2023-04
Alternative Title
膵癌におけるラウリン酸による低酸素誘導性ゲムシタビン抵抗性の克服
Degree grantor/type
奈良県立医科大学
Date Granted
2024-03-14